Stopping GLP-1 drugs may quickly raise heart attack and stroke risk
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Washington University researchers tracked more than 333,000 U.S. veterans with type 2 diabetes for three years and found cardiovascular benefits from GLP-1 drugs such as Ozempic, Wegovy, Mounjaro and Zepbound fade soon after treatment stops. Even six months off raised major event risk; after two years without therapy, heart attack, stroke and death risk was up to 22% higher than for patients who stayed on the drugs, according to BMJ Medicine.
Continue in the app — vote & join in ➔Source: ScienceDaily · via ahirlevel.hu